Previous Page  6 / 11 Next Page
Information
Show Menu
Previous Page 6 / 11 Next Page
Page Background

Page 32

allied

academies

J Med Oncl Ther 2017 | Volume 2 Issue 3

Breast Cancer

November 01-02, 2017 | Toronto, Canada

7

th

World Congress on

C

olorectal cancer (CR) is the second most common cause

of cancer death in Uganda. Although outcomes have

improved, it is clear that from a genomic standpoint CR is not

one disease, but a heterogeneous group of malignancies that

arise within one organ. Given that different subtypes have

different outcomes, the ability to subtype tumours in the

clinic would be highly favourable, enabling optimal treatment

for individual patients. In 2015, a consortium proposed

four consensus subtypes for CRC (MSI immune, canonical,

metabolic, and mesenchymal) based on six classifications

systems reported to have prognostic value. However,

genomic assessment of tumours is not readily translated

into routine pathology with a need for standardisation and

reproducibility of assessment. Immunohistochemistry is

widely used in routine pathology, and would present a more

readily translatable method for subtyping CRC tumours.

Therefore, the literature was reviewed to characterise the

genomic and phenotypic features associated with each

subtype, with the aim of enabling subtyping of CRC to be

taken forward into routine clinical practice.

e:

info@ugsites.com

Colorectal cancer subtypes: Translation to routine clinical pathology

Kyomukama Prisca

Rubaga Division, Uganda